|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.30 USD | +10.20% |
|
+0.86% | - |
| 06-29 | Avalyn Pharma Inc.(NasdaqGS:AVLN) added to Russell 2000 Index | CI |
| 06-29 | Avalyn Pharma Inc.(NasdaqGS:AVLN) added to Russell 2000 Value Benchmark | CI |
| Market Cap | 1.25B 1.1B 1.01B 933M 1.76B 121B 1.8B 12.09B 4.76B 59.17B 4.71B 4.61B 204B | P/E 2026 * |
-9.86x | P/E 2027 * | -11.7x |
|---|---|---|---|---|---|
| Enterprise Value | 1.26B 1.1B 1.02B 938M 1.77B 122B 1.81B 12.17B 4.79B 59.53B 4.74B 4.64B 205B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
100% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Avalyn Pharma Inc.
| 1 day | +10.20% | ||
| 1 week | +0.86% | ||
| Current month | -14.03% | ||
| 1 month | -10.02% |
| 1 week | 24.9 |  | 29.27 |
| 1 month | 24.9 | | 33.32 |
| Current year | 24.15 | | 33.32 |
| 1 year | 24.15 | | 33.32 |
| 3 years | 24.15 | | 33.32 |
| 5 years | 24.15 | | 33.32 |
| 10 years | 24.15 | | 33.32 |
| Manager | Title | Age | Since |
|---|---|---|---|
Lyn Baranowski
CEO | Chief Executive Officer | 50 | 2022-10-13 |
Douglas Carlson
DFI | Director of Finance/CFO | 47 | 2024-04-30 |
Howard Lazarus
CTO | Chief Tech/Sci/R&D Officer | 60 | 2023-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Heather Turner
CHM | Chairman | 53 | 2024-09-30 |
Tiba Aynechi
BRD | Director/Board Member | 50 | 2017-02-28 |
Ketan Patel
BRD | Director/Board Member | 51 | 2017-02-28 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 5/1/26 | F-Prime, Inc.
| Conversion | Company | -225,843 | 1.1116% | |
| 5/1/26 | F-Prime, Inc.
| Conversion | Company | -727,585 | 1.4654% | |
| 5/1/26 | Novo Holdings A/S (Investment Company)
| Conversion | Company | 67,914,626 | 153.2645% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +10.20% | +0.86% | - | - | 1.25B | |
| +0.24% | -1.54% | +52.85% | +60.31% | 53.83B | |
| -7.17% | -4.39% | +42.72% | +73.70% | 52.1B | |
| +0.80% | -6.31% | +5.62% | +413.12% | 23.48B | |
| -0.09% | -0.01% | -16.85% | -16.17% | 23.13B | |
| -5.95% | -2.58% | +29.53% | -7.67% | 19.36B | |
| -1.14% | +0.03% | +31.67% | -31.21% | 17.56B | |
| -5.16% | -7.00% | +168.44% | +291.24% | 15.2B | |
| -6.91% | -5.83% | +25.17% | +636.97% | 14.83B | |
| +0.43% | -1.03% | +25.75% | +186.18% | 14.06B | |
| Average | -1.48% | -2.28% | +40.54% | +178.50% | 23.48B | |
| Weighted average by Cap. | -2.73% | -2.34% | +39.55% | +137.89% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -108M -94.62M -87.32M -80.48M -152M -10.43B -155M -1.04B -410M -5.11B -407M -398M -17.58B | -110M -95.95M -88.54M -81.61M -154M -10.57B -157M -1.06B -416M -5.18B -412M -403M -17.83B |
| Net Debt | 7.65M 6.69M 6.17M 5.69M 10.72M 737M 10.96M 73.75M 29.01M 361M 28.74M 28.11M 1.24B | -453M -396M -365M -337M -635M -43.62B -649M -4.37B -1.72B -21.36B -1.7B -1.66B -73.54B |
Employees
50
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-17 | US$28.30 | +10.20% | 364,051 |
| 26-07-16 | US$25.68 | -6.28% | 289,727 |
| 26-07-15 | US$27.40 | -3.11% | 232,141 |
| 26-07-14 | US$28.28 | +1.58% | 203,783 |
| 26-07-13 | US$27.84 | -0.78% | 247,500 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
28.30USD
Average target price
59.00USD
Spread / Average Target
+108.48%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AVLN Stock
Select your edition
All financial news and data tailored to specific country editions
